← Back to Search

Treatment for Kidney Cancer (ODYSSEY RCC Trial)

N/A
Recruiting
Led By Daniel George, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, every 3 months for 2 years, every 6 months for up to 36 months
Awards & highlights

Summary

ODYSSEY RCC is a prospective, observational Phase IV study is to understand the cancer management and health-related quality of life in patients with mRCC in routine real-world clinical practice in the United States, including both community and academic treatment settings.

Eligible Conditions
  • Kidney Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, every 3 months for 2 years, every 6 months for up to 36 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, every 3 months for 2 years, every 6 months for up to 36 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in medication adherence as measured by patient report.
Change in quality of life in mRCC patients receiving therapy as measured by FACT-G
Change in quality of life in mRCC patients receiving therapy as measured by FKSI-19
+2 more
Secondary outcome measures
Concomitant glucocorticoid use
Dose holds and dose interruptions
Dosing (starting dose, dose intensity, ending dose)
+8 more

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,424 Previous Clinical Trials
3,065,284 Total Patients Enrolled
Duke Clinical Research InstituteOTHER
65 Previous Clinical Trials
241,011 Total Patients Enrolled
Bristol-Myers SquibbIndustry Sponsor
2,678 Previous Clinical Trials
4,124,845 Total Patients Enrolled
~329 spots leftby Jul 2026